TECHWIRE 30
(CIX: WRAL30)  1,083.64  down arrow-41.4  (-3.68 %)  Updated: 08:10 PM EDT, Jun 24 2016
(NQ: Apple)  93.40  down arrow-2.7  (-2.81 %)  Updated: 08:10 PM EDT, Jun 24 2016
(NY: Q)  63.32  down arrow-1.7  (-2.61 %)  Updated: 08:04 PM EDT, Jun 24 2016
(OP: BASFY)  74.59  down arrow-7.6  (-9.25 %)  Updated: 05:20 PM EDT, Jun 24 2016
(NQ: BCRX)  2.84  down arrow-0.1  (-3.4 %)  Updated: 08:10 PM EDT, Jun 24 2016
(NQ: BDSI)  2.27  down arrow-0.12  (-5.02 %)  Updated: 08:10 PM EDT, Jun 24 2016
(NQ: CEMP)  17.41  down arrow-1.15  (-6.2 %)  Updated: 08:10 PM EDT, Jun 24 2016
(NQ: Cisco)  27.75  down arrow-1.47  (-5.03 %)  Updated: 08:10 PM EDT, Jun 24 2016
(NQ: CREE)  23.90  down arrow-1.3  (-5.16 %)  Updated: 08:10 PM EDT, Jun 24 2016
(NQ: DARA)  0.88    (0 %)  Updated: 08:10 PM EST, Dec 04 2015
(NY: EMC)  27.29  down arrow-0.57  (-2.05 %)  Updated: 08:04 PM EDT, Jun 24 2016
(NQ: EXTR)  3.29  down arrow-0.29  (-8.1 %)  Updated: 08:10 PM EDT, Jun 24 2016
(NQ: Facebook)  112.08  down arrow-3  (-2.61 %)  Updated: 08:10 PM EDT, Jun 24 2016
(NY: GSK)  40.80  down arrow-1.76  (-4.14 %)  Updated: 08:04 PM EDT, Jun 24 2016
(NQ: Alphabet)  675.22  down arrow-26.65  (-3.8 %)  Updated: 08:10 PM EDT, Jun 24 2016
(NY: IBM)  146.59  down arrow-8.76  (-5.64 %)  Updated: 08:04 PM EDT, Jun 24 2016

Posts tagged “NCBIO”

Updated 11:20 a.m. Thursday

Looking for startup cash? SEBIO pitch deadline is July 1

SEBIO If your early-stage life science company needs some funding help, you still have a few days to apply for a chance to pitch your company story to investors and colleagues at the 2016 annual Southeast BIO Investor & Partnering Forum.

Updated April 4

Premium Lock Tech-focused business groups wary of HB2 or take no position

HB2 debate   Power pro-business advocacy groups who also have a focus on or include members of the high tech and life science industries are either analyzing the recently passed Public Facilities Privacy & Security Act or steering clear of any comment.

March 3

Premium Lock From gene editing to microbiome, precision medicine to big data and more: NC's bright biotech future

CED Life Science Conference 2016 Doug Edgeton, CEO of the North Carolina Biotechnology Center, gave a thumb's up overview about the state's life science sector in a briefing to the boards of the Biotech Center, the CED and NCBio earlier this week. Here's a recap.

January 25

Premium Lock Fred Eshelman to receive CED's Life Science Leadership Award

Fred Eshelman   Veteran entrepreneur, philanthropist and investor Fred Eshelman will receive the Life Science Leadership Award at the 25th annual CED Life Science Conference in March.

December 17, 2015

Premium Lock Veteran life science exec Tom Stabb is new chair of NCBIO

NCBIO Tom Staab, who has worked with a number of life science firms in the Triangle, is the new chairman of the biotech trade organization NCBIO.

November 9, 2015

Premium Lock CED announces keynote speaker for the CED Life Science Conference

Robert J. Lefkowitz, M.D. Entrepreneurial support organization CED announced that Robert J. Lefkowitz, MD will be the keynote speaker for their annual CED Life Science Conference, held this year March 1-2, 2016.

Updated October 21, 2015

Premium Lock NCBIO annual meeting includes legislative review

NCBIO NCBIO, the trade organization for North Carolina biotechnology companies, expects about 200 to 250 at its annual meeting at the NC Biotechnology Center Thursday. Sam Taylor, NCBIO president, said that in addition to two key note speakers, the event includes a review of state and federal policies related to biotech, including what the NC legislature did this year.

February 11, 2015

Premium Lock Biotech conference to feature 13 emerging NC companies

Biotech & Life Science Thirteen emerging startup life science companies will share the spotlight at the annual Life Science Conference put on by the Council for Entrepreneurial Development, NCBIO and the North Carolina Biotechnology Center in Raleigh.

February 28, 2014

Premium Lock FDA commissioner delivers a life science innovation pep talk

"Innovation isn't important simply because it creates something new - it's only important if what it creates makes a meaningful and positive difference in people's lives," says FDA Commissioner Dr. Margaret Hamburg.

VIPs on stage at CED conference VIPs on stage at CED conference

Updated February 11, 2014

Premium Lock CED picks five startups to present at Life Science Conference

CED BioKier, CanDiag, Improved Patient Outcomes, KinoDyn, and Nova Synthetix will each get a chance to pitch potential investors during the "Innovation Showcase" on Feb. 26.

February 11, 2013

Premium Lock LabCorp to lead Venture Day at CED Life Science conference

LabCorp, the global lab testing firm based in Burlington, and its Chief Executive Officer David King are the host for "Venture Day" at the CED's annual life science conference.

CED Life Science conference CED Life Science conference

January 3, 2013

Premium Lock Nobel Prize winner headlines CED Life Science Conference program

Dr. Jack Szostak, a 2009 Nobel Prize winner and a professor of genetics at Harvard, headlines the program for the 22nd CED Life Science Conference next month.

CED Life Science Conference CED Life Science Conference

June 14, 2012

Premium Lock N.C. biotech sector to have big 'footprint' at BIO event

The N.C. Biotechnology Center and other representatives for the state's biotech industry will have a new 3,000 square foot pavillion at the BIO International Convention.

North Carolina's new 3,000 square foot pavilion North Carolina's new 3,000 square foot pavilion

Updated December 22, 2011

Premium Lock Opinion: New life sciences cluster report presents skewed view of RTP's activities

RTP The Triangle is outstanding for life sciences whether reports on U.S. markets score it first, last or in the middle.

October 4, 2010

Premium Lock Sanofi-Aventis launches Genzyme takeover battle

Genzyme France’s Sanofi-Aventis on Monday launched an $18.5 billion hostile takeover attempt for Genzyme Corp., escalating the battle after the U.S. biotech company’s management twice rejected its offer.

Tags: NCBIO
February 21, 2010

Premium Lock CED’s 19th annual Biotech Conference opens Monday in Raleigh

CED Biotech Conference One-on-one partnership meetings are among the event’s highlights. Former Embrex executive will receive top life science honor.

Updated November 16, 2009

Premium Lock Addrenex being bought by Sciele

Addrenex The Atlanta-based buyer will pay about $29 million for developmental drugs it didn't already own.

Updated May 11, 2009

Premium Lock CED’s Medtech conference to highlight emerging medical device industry in N.C.

CED to showcase Medtech In a state where biotech dominates life science headlines, device company execs and CED band together to raise the industry profile. They also want other companies to become more aware of N.C.’s advantages as a home for emerging ventures.

Updated April 17, 2009

Premium Lock ‘We Work for Health’ – New group seeks to spark medical innovation in N.C.

Sam Taylor Biotech, pharmaceutical and medical science firms across the state form ‘one of the biggest life science engines in the country,’ NCBIO executive tells group at kickoff event. He cautions against changes that would ‘undermine’ that engine.

Tags: NCBIO, GSK
Updated March 18, 2009

Premium Lock Biotech Center provides $2.5M to launch medical device center

 Advanced Medical Technology Center for Innovation is set to launch in May. NCBIO led research effort for project. Search for director is under way.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith